{"id":"W4410818215","doi":"10.1200/jco.2025.43.16_suppl.tps4630","title":"ABLE-22: Safety and efficacy evaluation of nadofaragene firadenovec alone or in combination with chemotherapy or immunotherapy—A randomized, open-label, phase 2 study.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; McGill University Health Centre","funders":"","keywords":"Medicine; Oncology; Immunotherapy; Open label; Chemotherapy; Internal medicine; Randomized controlled trial; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002225401,0.001656571,0.002140924,0.0004298952,0.0002877594,0.001183258,0.0009735706,0.001753523,0.007509955],"category_scores_gemma":[0.001227433,0.0007096295,0.001695169,0.0004104635,0.001106956,0.001247557,0.0003548295,0.002767776,0.001237763],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006901494,"about_ca_system_score_gemma":0.001070818,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005783152,"about_ca_topic_score_gemma":0.00132728,"domain_scores_codex":[0.9994135,0.0003045489,0.00002800368,0.0001178875,0.00005484434,0.00008128754],"domain_scores_gemma":[0.9990916,0.0001911166,0.0002380012,0.00008114071,0.0000539709,0.000344151],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9207322,0.03991259,0.0009247444,0.0006918869,0.001183024,0.00006233955,0.00005899263,0.0004379692,0.009961722,0.0001037004,0.001166259,0.02476461],"study_design_scores_gemma":[0.7140058,0.2801497,0.002210785,0.00003094773,0.000494623,0.0000766009,0.00002199543,0.0004262173,0.001171404,0.0001061215,0.00128319,0.00002269225],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.985776,0.004548422,0.0009079059,0.0003812858,0.0003193664,0.00407633,0.001797549,0.0001647558,0.002028437],"genre_scores_gemma":[0.9863788,0.002612711,0.001644285,0.0009226361,0.0003665928,0.003425325,0.0017781,0.00004277869,0.0028287],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007509955,"threshold_uncertainty_score":0.0251233,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1761127251326121,"score_gpt":0.5627920855961613,"score_spread":0.3866793604635492,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}